Log in to save to my catalogue

A10.2 Anti-AT1R and Anti-Etar Autoantibodies in Pathogenesis of Systemis Sclerosis

A10.2 Anti-AT1R and Anti-Etar Autoantibodies in Pathogenesis of Systemis Sclerosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777884597

A10.2 Anti-AT1R and Anti-Etar Autoantibodies in Pathogenesis of Systemis Sclerosis

About this item

Full title

A10.2 Anti-AT1R and Anti-Etar Autoantibodies in Pathogenesis of Systemis Sclerosis

Publisher

Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2013-03, Vol.72 (Suppl 1), p.A72

Language

English

Formats

Publication information

Publisher

Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

Background and Objectives SSc is a prototypic multiorgan disease characterised by vascular damage, autoimmunity and fibrosis with still unkown aetiology. Recently identified functional autoantibodies simultaneously targeting the angiotensin-II type-1 receptor (AT1R-Abs) and the endothelin-1 receptor type A (ETAR-Abs) were linked to vascular and fib...

Alternative Titles

Full title

A10.2 Anti-AT1R and Anti-Etar Autoantibodies in Pathogenesis of Systemis Sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1777884597

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1777884597

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2013-203224.2

How to access this item